Electron transfer flavoprotein (ETF)

Electron transfer flavoprotein (ETF) is a heterodimeric mitochondrial enzyme comprised of alpha (ETFA) and beta (ETFB) subunits, each encoded by separate nuclear genes[1][6]. ETF is mainly located on the matrix face of the inner mitochondrial membrane and acts as a key electron acceptor from at least 14 different mitochondrial flavoenzymes, including those involved in mitochondrial fatty acid β-oxidation and certain amino acid catabolism[1][6][5][7]. ETF assembles with one FAD (flavin adenine dinucleotide) and one AMP as cofactors, forming a molecular hub for the transfer of electrons into the mitochondrial respiratory chain at the level of ubiquinone (coenzyme Q), thereby linking dehydrogenase-derived reducing equivalents to oxidative phosphorylation[1][3][6]. ETF interacts with primary flavoprotein dehydrogenases and then relays electrons to the inner-membrane protein ETF:ubiquinone oxidoreductase (ETF:QO), which passes electrons to ubiquinone in the electron transport chain[1][3][6]. Structurally, ETFs have three domains; two contributed by ETFA and one by ETFB, stabilizing the electron transfer function[5][7][8]. Genetic defects in either ETFA or ETFB can cause multiple acyl-CoA dehydrogenase deficiency (MADD/glutaric acidemia type II), a severe human metabolic disorder characterized by defective energy metabolism[1][6]. ETF is not a classical drug target but is therapeutically relevant in inherited metabolic diseases; riboflavin supplementation is occasionally beneficial in certain ETF-deficient patients, functioning as a cofactor precursor[1][6]. No major approved drugs directly target ETF for other indications, but the protein is central to mitochondrial energy metabolism, redox biology, and the pathology of certain metabolic and, possibly, neurodegenerative disorders. ETF is sometimes referred to as “electron-transferring flavoprotein” or "electron transfer flavoprotein complex"[6]. In summary, electron transfer flavoprotein is a vital mitochondrial enzyme facilitating transfer of electrons from flavoenzyme-catalyzed metabolic oxidations to the respiratory chain, and its deficiency causes profound and sometimes fatal metabolic disease[1][6][7].

Other names

Electron-transferring flavoproteinETF complexCETF (electron transfer flavoprotein complex)ETFA (alpha subunit)ETFB (beta subunit)

Drugs such as riboflavin may act as cofactor precursors, enhancing residual ETF activity in deficiency; agents targeting ETF indirectly may modulate mitochondrial energy metabolism